4//SEC Filing
ORiordan Anne 4
Accession 0001765581-22-000094
CIK 0001232524other
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:36 PM ET
Size
6.4 KB
Accession
0001765581-22-000094
Insider Transaction Report
Form 4
ORiordan Anne
Director
Transactions
- Sale
Ordinary Shares
2022-08-08$152.32/sh−1,089$165,877→ 10,717 total - Award
Ordinary Shares
2022-08-05+2,561→ 11,806 total
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023.
- [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001767870
Filing Metadata
- Form type
- 4
- Filed
- Aug 8, 8:00 PM ET
- Accepted
- Aug 9, 6:36 PM ET
- Size
- 6.4 KB